Pieter Gillard

Leuven, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 114 publications

CGM Metrics and the Risk of Pregnancy Complications in Type 1 Diabetes: A Secondary Exploratory Analysis of the CRISTAL Trial.

CGM Metrics and the Risk of Pregnancy Complications in Type 1 Diabetes: A Secondary Exploratory Analysis of the CRISTAL Trial.

Journal: Diabetes technology & therapeutics

Published: August 12, 2026

A reference framework for continuous glucose monitoring training and education among healthcare professionals - a multidisciplinary expert consensus.

A reference framework for continuous glucose monitoring training and education among healthcare professionals - a multidisciplinary expert consensus.

Journal: Diabetes research and clinical practice

Published: May 21, 2026

Weight and HbA1c trajectories following initiation of continuous glucose monitoring in adults with type 1 diabetes: a cohort study using group-based multi-trajectory analysis.

Weight and HbA1c trajectories following initiation of continuous glucose monitoring in adults with type 1 diabetes: a cohort study using group-based multi-trajectory analysis.

Journal: The Lancet regional health. Europe

Published: March 31, 2026

The Correlation Between Fear and Perceived Frequency of Hypoglycemia and Continuous Glucose Monitoring Metrics in Adults With Type 1 Diabetes Using Diabetes Technology: A One-Year Analysis.

The Correlation Between Fear and Perceived Frequency of Hypoglycemia and Continuous Glucose Monitoring Metrics in Adults With Type 1 Diabetes Using Diabetes Technology: A One-Year Analysis.

Journal: Diabetes care

Published: March 31, 2026

Cost-Utility Analysis of Control-IQ Technology Relative to Conventional Insulin Therapy in Adults with Type 1 Diabetes.

Cost-Utility Analysis of Control-IQ Technology Relative to Conventional Insulin Therapy in Adults with Type 1 Diabetes.

Journal: Diabetes technology & therapeutics

Published: December 30, 2025

Continuous glucose monitoring as a tool in early-stage type 1 diabetes.

Continuous glucose monitoring as a tool in early-stage type 1 diabetes.

Journal: Diabetologia

Published: October 14, 2025

EndoCompass Project: Research Roadmap for Diabetes, Obesity, and Metabolism.

EndoCompass Project: Research Roadmap for Diabetes, Obesity, and Metabolism.

Journal: Hormone research in paediatrics

Published: October 14, 2025

Who Benefits Most from Advanced Hybrid Closed Loop Therapy in Pregnancy Across Different Subgroups: A Secondary Analysis of the Randomized Controlled CRISTAL Trial.

Who Benefits Most from Advanced Hybrid Closed Loop Therapy in Pregnancy Across Different Subgroups: A Secondary Analysis of the Randomized Controlled CRISTAL Trial.

Journal: Diabetes technology & therapeutics

Published: September 23, 2025

One-year effectiveness and safety in young children aged 2-6 years with type 1 diabetes using an automated insulin delivery system: A real-world prospective cohort study.

One-year effectiveness and safety in young children aged 2-6 years with type 1 diabetes using an automated insulin delivery system: A real-world prospective cohort study.

Journal: Diabetes, obesity & metabolism

Published: August 19, 2025

Tubeless automated insulin delivery versus multiple daily injections in children and adults with type 1 diabetes with elevated HbA1c (RADIANT): a multicentre, international, parallel-group, open-label, randomised, controlled trial.

Tubeless automated insulin delivery versus multiple daily injections in children and adults with type 1 diabetes with elevated HbA1c (RADIANT): a multicentre, international, parallel-group, open-label, randomised, controlled trial.

Journal: The lancet. Diabetes & endocrinology

Published: August 18, 2025

The Use of Continuous Glucose Monitoring to Diagnose Stage 2 Type 1 Diabetes.

The Use of Continuous Glucose Monitoring to Diagnose Stage 2 Type 1 Diabetes.

Journal: Journal of diabetes science and technology

Published: May 30, 2025

Trends in baseline HbA1c and body-mass index in randomised trials of people with type 1 diabetes from 1993 to 2025: an IMI2 SOPHIA systematic review and meta-analysis.

Trends in baseline HbA1c and body-mass index in randomised trials of people with type 1 diabetes from 1993 to 2025: an IMI2 SOPHIA systematic review and meta-analysis.

Journal: EClinicalMedicine

Published: March 20, 2025

Showing 1-12 of 114

Last Updated: 09/26/2026